Tatva Chintan Pharma Chem Limited has been one of the leaders in the manufacturing of SDAs in India. The company initiated its operations in 1996. It has exposure across various industries namely agrochemicals, automotive, pigments, petroleum, pharmaceutical, paints and coatings and personal care. Its major revenue comes through export business. The company exports its products to more than 23 countries. There is a 76% share of exports in the company’s revenue. However the company has only domestic manufacturing facilities at Ankleshwar and Dahej.
IPO DETAILS
The Tatva Chintan Pharma Chem Limited IPO is set to launch on 16th July, 2021. The subscription timeline extends till 20th July, 2021. The size for the IPO is 500 Crore Rs. Shares issued through Offer for sale are 275 Crore Rs. Shares worth Rs. 225 Crore are issued through Fresh issue. The minimum lot size is 195 shares and the price is set at 1073 Rs. – 1083 Rs./ share. The company is going to get listed at both the exchanges NSE and BSE. The face value per share is Rs. 10 and this is a book built issue. The registrar for the company is Link Intime India Private Limited.
TABULAR REPRESENTATION OF IPO DETAILS
IPO OPENING DATE | 16th July, 2021 |
IPO CLOSING DATE | 20th July, 2021 |
ISSUE TYPE | Book Built Issue |
Face Value per share | 10 Rs. per share |
IPO price band | 1073 Rs. – 1083 Rs. |
LOT SIZE | 13 shares |
MINIMUM ORDER QUANTITY | 13 shares |
ISSUE SIZE | 500 Crore Rs. |
OFFER FOR SALE | 275 Crore Rs. |
FRESH ISSUE | 225 Crore Rs. |
LISTING AT | NSE, BSE |
LISTING DATE | 29th July, 2021 |
IMPORTANT DATES
IPO OPENING DATE | 16th July, 2021 |
IPO CLOSING DATE | 20th July, 2021 |
IPO ALLOTMENT DATE | 26th July, 2021 |
REFUNDS | 27th July, 2021 |
DEMAT A/C CREDITED ON | 28th July, 2021 |
IPO LISTING DATE | 29th July, 2021 |
The Tatva Chintan Pharma Chem Limited IPO begins for subscription from 16th July, 2021. The IPO subscription would continue till 20th July, 2021. The allotment status for the shareholders who applied would come on 26th July, 2021. The refunds for the ones who did not get allotment would be initiated on 27 July, 2021. The DEMAT accounts of shareholders would be credited on 28th July, 2021. The listing of the company would be accompanied on 29th July, 2021.
PROMOTER AND LEAD MANAGERS
The promoters for Tatva Chintan Pharma Chem Ltd. are Chintan Nitinkumar Shah, Ajaykumar Patel and Snehkar Somani. The promoter holding pre IPO launch is 100% and it will get decreased to 79.17% post IPO launch.
The lead managers for the company are :
- JM Financial Consultants Private Limited
- ICICI Securities Limited
The minimum lot size for the company is decided at 13 shares. This holding accounts to Rs. 14079. The maximum lot size is decided at 182 shares. This amounts to Rs. 197106. Hence the company’s final holdings would be set as :
Shares | Amount | |
Minimum | 13 shares | 14079 Rs. |
Maximum | 182 shares | 197106 Rs |
OBJECTIVES FOR THE IPO
- The money from the IPO can also be utilized to meet general corporate purposes.
- The company is planning to expand its manufacturing plants at Dahej. Thus the money will be utilized to fulfill this purpose.
- The company has its Research and Development facility at Vadodara. The expansion of it is also one added reason for use of IPO funds.
COMPANY FINANCIALS
Particulars (in Million Rs.) | 2020-21 | 2019-20 | 2018-19 |
ASSETS | 3148 | 2489 | 1875 |
REVENUE | 3062 | 2646 | 2068 |
NET PROFIT | 522 | 377 | 205 |
The company has been able to perform consistently well. It has produced outstanding profits from a limited asset base. The assets of the company have increased two times in the span of 3 years. The revenues have also increased in a consistent manner with assets. The profit margin for the company is really outstanding. The company is generating close to 18% profits from asset base and revenues. This is the reason why the company sounds good to invest in. Also the expansion plans of the company triggers the long term growth perspectives of the company.
PROS
- Export ties for better sales developments.
- Company is active in the SDA production.
- The company has performed consistently well on its financial fronts.
- Tatva Chem has a diversified product portfolio.
- Manufacturing facilities and R&D facilities at Gujarat.
CONS
- Increased raw material costing and transportation costs due to domestic production.
- More revenue is concentrated on certain clients only.
TATVA CHINTAN PHARMA CHEM LTD. IPO APPLICATION PROCESS WITH ZERODHA
It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :
- Logging into Zerodha console through its website or KITE platform.
- Clicking the IPO link present in the Portfolio section
- Click the Tatva Chintan Pharma Chem IPO button and press the BID button
- Entering the details asked for like UPI ID, Quantity and price
- Submit the application form of IPO
- Visiting the application of UPI for approving the transaction
Now, applying for an IPO online is possible with most of the Discount and online brokers.